Literature DB >> 10516707

Graft-versus-myeloma after withdrawal of immunosuppression following allogeneic peripheral stem cell transplantation.

J Libura1, T Hoffmann, J Passweg, M Gregor, G Favre, A Tichelli, A Gratwohl.   

Abstract

There is growing evidence for a graft-versus-myeloma effect following allogeneic stem cell transplantation. We add to this evidence by reporting complete remission achieved by withdrawal of immunosuppression in a patient with multiple myeloma progressing after HLA-identical sibling peripheral stem cell transplantation. De novo chronic graft-versus-host disease coincided with the anti-myeloma effect and responded to treatment. The patient remains in complete remission 3 years after transplant.

Entities:  

Mesh：

Year:  1999        PMID： 10516707     DOI： 10.1038/sj.bmt.1701980

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


  8 in total

Review 1.  Allogeneic stem cell transplantation for multiple myeloma: is there a future?

Authors:  B Dhakal; D H Vesole; P N Hari
Journal:  Bone Marrow Transplant       Date:  2016-01-04       Impact factor: 5.483

Review 2.  Harnessing the T Cell to Treat Multiple Myeloma: Dawn of a New Therapeutic Paradigm.

Authors:  Alana L Keller; Daniel W Sherbenou; Peter A Forsberg; Tomer M Mark
Journal:  Front Oncol       Date:  2022-06-24       Impact factor: 5.738

Review 3.  Recent developments in hematopoietic stem cell transplantation for multiple myeloma.

Authors:  William I Bensinger
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

Review 4.  Is there still a role for allogeneic stem-cell transplantation in multiple myeloma?

Authors:  William I Bensinger
Journal:  Best Pract Res Clin Haematol       Date:  2007-12       Impact factor: 3.020

5.  Role of allogeneic transplantation in multiple myeloma in the era of new drugs.

Authors:  Benedetto Bruno; Luisa Giaccone; Moreno Festuccia; Mario Boccadoro
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-06-01       Impact factor: 2.576

Review 6.  Evolving paradigms in the treatment of relapsed/refractory multiple myeloma: increased options and increased complexity.

Authors:  R F Cornell; A A Kassim
Journal:  Bone Marrow Transplant       Date:  2016-01-04       Impact factor: 5.483

Review 7.  Allograft for Myeloma: Examining Pieces of the Jigsaw Puzzle.

Authors:  Ehsan Malek; Najla El-Jurdi; Nicolaus Kröger; Marcos de Lima
Journal:  Front Oncol       Date:  2017-12-11       Impact factor: 6.244

8.  Graft-Versus-Host Disease in Multiple Myeloma Patients Treated With Daratumumab After Allogeneic Transplantation.

Authors:  Liana Nikolaenko; Saurabh Chhabra; Noa Biran; Arnab Chowdhury; Parameswaran N Hari; Amrita Krishnan; Joshua Richter
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2020-01-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.